Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- befree-2016 importedOn "2016-02-19" NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_assertion wasGeneratedBy ECO_0000203 NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_assertion wasDerivedFrom befree-2016 NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_assertion SIO_000772 22012255 NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_assertion evidence source_evidence_literature NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.